BioXcel Therapeutics (BTAI) Change in Account Payables (2018 - 2019)
BioXcel Therapeutics' (BTAI) quarterly Change in Account Payables came in at $4000.0 in Q1 2019, down 69.23% year-on-year from $13000.0 in Q1 2018, and down 69.23% quarter-over-quarter from $13000.0 in Q1 2018.
BioXcel Therapeutics (BTAI) Change in Account Payables (2018 - 2019) Analysis & Trends
BioXcel Therapeutics' Change in Account Payables history runs 2 years deep, the most recent figure standing at $4000.0 for Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 27.69 Bn | 23.63 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.12 Bn | 20.97 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.24 Bn | 18.44 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.64 Bn | 12.22 Bn | 785.00 Mn | - |
| 10 | BioXcel Therapeutics | 19.95 Mn | 19.95 Mn | -77,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 4,000.00 |
| Mar 31, 2019 | 4,000.00 |
| Mar 31, 2018 | 13,000.00 |
| Mar 31, 2018 | 13,000.00 |